Clin2
NCT06893016Likely a fitRecruiting

Study of RAY1225 for adults with obesity or overweight

Obesity

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests a new medicine called RAY1225 to help people lose weight. If you have obesity or are overweight with related health conditions, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
640 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • Your body mass index (BMI) is 28 or higher, or your BMI is between 24 and 28 with at least one health issue like high blood pressure, high cholesterol, sleep apnea, fatty liver, heart disease, or PCOS.
  • You have tried and failed to lose weight with diet and exercise at least once.
  • You do not have a type of obesity caused by a specific gene, another disease, or medication.
  • You have no personal or family history of a rare thyroid cancer (medullary thyroid carcinoma) or a genetic condition called MEN2.
  • You do not have moderate or severe depression, or a history of bipolar disorder, schizophrenia, or other serious psychiatric conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06254261Recruiting· Phase 2
RAY1225 for weight loss in obesity

This study tests an investigational medication called RAY1225 in people with obesity. It's given as an injection and may help with weight loss by targeting hormones that control appetite.

Beijingcun, Hebei
NCT07725809Not yet recruiting· Phase 1
Study of a new medicine for adults with overweight or obesity

This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.

Brussels, Bruxelles-capitale, Région de
NCT06606483Not yet recruiting· Phase 2
Study of MDR-001 in adults with obesity or overweight

This study tests a new medication called MDR-001 for helping people lose weight. It is for adults who are either obese or overweight with related health issues. The goal is to see if the drug is safe and effective for weight loss.

Hefei, Anhui
NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas
NCT07339423Recruiting· Phase 3
A study of a new medicine for weight loss

This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.

Miramar, Florida
NCT06143956Recruiting· Phase 2
Weight loss treatments for adults with obesity

This clinical trial tests new treatments for adults who are overweight or have obesity. The goal is to help people lose weight and improve their health.

Chandler, Arizona

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.